535 related articles for article (PubMed ID: 16293160)
1. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
Brunsvold AN; Wung SF; Merkle CJ
J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
[TBL] [Abstract][Full Text] [Related]
2. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
3. Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.
Tinelli A; Malvasi A; Leo G; Vergara D; Pisanò M; Ciccarese M; Chiuri VE; Lorusso V
Cancer Metastasis Rev; 2010 Jun; 29(2):339-50. PubMed ID: 20405170
[TBL] [Abstract][Full Text] [Related]
4. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
5. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
6. Hereditary ovarian cancer--assessing risk and prevention strategies.
Pavelka JC; Li AJ; Karlan BY
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):651-65, vii-viii. PubMed ID: 18061862
[TBL] [Abstract][Full Text] [Related]
7. High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.
Maehle L; Apold J; Paulsen T; Hagen B; Løvslett K; Fiane B; Van Ghelue M; Clark N; Møller P
Clin Cancer Res; 2008 Nov; 14(22):7569-73. PubMed ID: 19010876
[TBL] [Abstract][Full Text] [Related]
8. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
[TBL] [Abstract][Full Text] [Related]
9. The genetics of ovarian cancer: concepts in testing and counseling.
Hartenbach EM; Schink JC
Curr Opin Obstet Gynecol; 1996 Oct; 8(5):339-42. PubMed ID: 8941429
[TBL] [Abstract][Full Text] [Related]
10. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
[TBL] [Abstract][Full Text] [Related]
11. Fibromyalgia--management of a misunderstood disorder.
Peterson EL
J Am Acad Nurse Pract; 2007 Jul; 19(7):341-8. PubMed ID: 17680899
[TBL] [Abstract][Full Text] [Related]
12. A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision.
Friedenson B
MedGenMed; 2001 Nov; 3(6):2. PubMed ID: 11965197
[TBL] [Abstract][Full Text] [Related]
13. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses.
Russo A; Calò V; Agnese V; Bruno L; Corsale S; Augello C; Gargano G; Barbera F; Cascio S; Intrivici C; Rinaldi G; Gulotta G; Macaluso M; Surmacz E; Giordano A; Gebbia N; Bazan V
Breast Cancer Res Treat; 2007 Nov; 105(3):267-76. PubMed ID: 17221156
[TBL] [Abstract][Full Text] [Related]
15. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
Struewing JP; Lerman C; Kase RG; Giambarresi TR; Tucker MA
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):169-73. PubMed ID: 7742725
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer and the family tree. An issue for all practice settings.
Edwards QT; Seibert D; Maradiegue A; MacDonald D; Jasperson K; Lowstuter K; Weitzel J
Adv Nurse Pract; 2007 May; 15(5):34-41; quiz 41-2. PubMed ID: 20000211
[No Abstract] [Full Text] [Related]
17. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Roukos DH; Briasoulis E
Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
[TBL] [Abstract][Full Text] [Related]
18. Familial breast and ovarian cancers.
Arai M; Utsunomiya J; Miki Y
Int J Clin Oncol; 2004 Aug; 9(4):270-82. PubMed ID: 15375703
[TBL] [Abstract][Full Text] [Related]
19. Familial ovarian cancer.
Elit L
Can Fam Physician; 2001 Apr; 47():778-84. PubMed ID: 11340759
[TBL] [Abstract][Full Text] [Related]
20. Women's decisions regarding management of breast cancer risk.
MacDonald DJ
Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
